AI assistant
Sending…
IMMUCELL CORP /DE/ — Director's Dealing 2015
Nov 13, 2015
34519_dirs_2015-11-13_bcbe317c-226a-4797-8d85-308f748dfd99.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2015-11-11
Reporting Person: ROTHSCHILD JONATHAN E (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-11-11 | Common Stock, par value $0.10 per share | P | 24000.0000 | $0.0000 | Disposed | 500636.0000 | Direct |
Footnotes
F1: These 24,000 shares were distributed from the estate of Mr. Rothschild's parents to the two sisters of Mr. Rothschild, as to which Mr. Rothschild disclaims beneficial ownership. Mr. Rothschild is the executor of his parents' estate and now owns 19,255 shares from the estate directly, which are included in the 500,636 shares disclosed above in Table I, Column 5.
F2: This figure includes 221,655 shares of common stock held by Arterio Inc., a corporation owned solely by Mr. Rothschild.
More from IMMUCELL CORP /DE/
Regulatory Filings
2026
May 14
Annual Report
2026
May 13
Regulatory Filings
2026
May 8
Proxy Solicitation & Information Statement
2026
Apr 24
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 8
Annual Report
2026
Mar 30
Director's Dealing
2026
Mar 25
Director's Dealing
2026
Mar 23